Hijacked receptors

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 2-3, 2000, Pages 287-290

  Triggle, David J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Chemokine receptors; Chemokines; Co evolution; G protein coupled receptors; Ligand receptor interactions; Promiscuity; Receptor coupling; Receptors; Viral penetration

Indexed keywords

BLOOD GROUP ANTIGEN; CHOLINERGIC RECEPTOR; COMPLEMENT RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN RECEPTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

BACTERIAL INFECTION; CONFERENCE PAPER; ECHO VIRUS; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MYCOBACTERIUM LEPRAE; PLASMODIUM VIVAX; RABIES VIRUS; RECEPTOR BINDING; RHINOVIRUS; ROUS SARCOMA ONCOVIRUS; SALMONELLA TYPHI; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION; VACCINIA VIRUS; VIRUS INFECTION;

ANIMALS; GTP-BINDING PROTEINS; HIV-1; HUMANS; LIGANDS; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS;

EID: 0034029693     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00054-0     Document Type: Conference Paper

References (24)

1. Arey B.J., Stevis P.E., Deecher D.C., Shen E.S., Frail D.E., Negro-Vilar A., Lopez F.J. Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms. Mol. Endocrinol. 11:1997;517-526.
2. Baba M., Nishimura O., Kanzaki N., Okamoto M., Sawada H., Izawa Y., Shiraishi M., Aramaki Y., Okonogi K., Ogawa Y., Meguro K., Fujino M. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity. Proc. Nat. Acad. Sci. U.S.A. 96:1999;5698-5703.
3. Bates P. Chemokine receptors and HIV-1: an attractive pair? Cell. 86:1996;1-3.
4. Bright C., Brown T.J., Halley F., Lockey P., McLay I.M., Moore U., Porter B., Williams R.J. Identification of a non-peptidic RANTES antagonist. Bioorg. Med. Chem. Lett. 8:1998;771-774.
5. Cairns J.S., D'Souza M.P. Chemokines and HIV-1 second receptors: the therapeutic connection. Nature Med. 4:1998;563-568.
6. Cundell D.R., Gerard N.P., Gerard C., Idanpaan-Helkkla I., Tuomanen E.I. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature. 377:1995;435-438.
7. Kaner R.J., Baird A., Mansukhani A., Basilico C., Summers B.D., Florkiewicz, Hajjar D.P. Fibroblast growth factor receptor factor receptor is a portal of cellular entry for herpes simplex virus type 1. Science. 248:1990;1410-1413.
8. Kenakin T. Agonist-receptor efficacy: I. Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci. 16:1995;188-192.
9. Kostensis E., Zeng F.Y., Wess J. Functional characterization of a series of mutant G protein alphaq subunits displaying promiscuous receptor coupling properties. J. Biol. Chem. 273:1998;17886-17892.
10. Kwon P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
11. Lentz T.L. Rabies virus receptors. Trends Neurosci. 7:1985;360-364.
12. Lentz T.L., Burrage T.G., Smith A.L., Crick J., Tignor G.H. Is the acetylcholine receptor a rabies virus receptor? Science. 215:1982;182-184.
13. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonaldm E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
14. Milligan G. Is promiscuity of G protein interaction an issue in the classification of receptors? Ann. N. Y. Acad. Sci. 812:1997;126-132.
15. Moyle W.R., Campbell R.K., Myers R.V., Bernard M.P., Han Y., Wang R.K. Co-evolution of ligand-receptor pairs. Nature. 368:1994;251-255.
16. Nishiyama Y., Murakami T., Kurita K., Yamamoto N. Low-molecular weight anti-HIV peptides for the amino-terminal sequence of RANTES: possible lead compounds for coreceptor-directed anti-HIV agents. Bioorg. Med. Chem. Lett. 9:1999;1357-1360.
17. Paxton W.A., Martin S.R., Tse D., O'Brien T.R., Skurnick J., VanDevanter N.L., Padian N., Braun J.F., Kotler D.P., Wolinsky S.M., Koup R.A. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nature Med. 2:1996;412-417.
18. Pier G.P., Grout M., Zaidi T., Meluleni G., Mueschenborn S.S., Banting G., Ratcliff R., Evans M.J., Colledge W.H. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature. 393:1998;79-92.
19. Proudfoot A.El., Wells T.N.C., Clapham P.R. Chemokine receptors - future therapeutic targets for HIV? Biochem. Pharmacol. 57:1999;451-463.
20. Rambukkana A., Yamada H., Zanazzi G., Mathus G., Salzer J.L., Yurchenco P.D., Campbell K.P., Fischetti V.A. Role of α-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science. 282:1998;2076-2081.
21. Robey E., Axel R. CD4: collaborator in immune recognition and HIV infection. Cell. 60:1990;697-700.
22. Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.-M., Saragosti S., Lapoumerouille C., Cognaux J.et al. resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature. 382:1996;722-725.
23. Sattentau Q.J., Weiss R.A. The CD4 antigen: physiological ligand and HIV receptor. Cell. 52:1988;631-633.
24. Wells T.N.C., Proudhoot A.El., Power C.A., Marsh M. Chemokine receptors - the new frontier for AIDS research. Chem. Biol. 3:1998;603-609.